Idenix Pharmaceuticals (IDIX)

[DewDiligence]

PROVE-1 predictions for patients undergoing
12-weeks of treatment with VX-950 + SoC:

 
        gofish   Dew  dewPhl goSeek  Katie 
 SVR12*   70%    72%    62%    70%    76% 
 SVR*     68%    66%    56%    60%    68% 

*Intent-to-treat (ITT) basis